Plasma exchange as a therapeutic option in patients with neurologic symptoms due to antibodies to voltage-gated potassium channels: A report of five cases and review of the literature

Journal of Clinical Apheresis

Volumn 27, Issue 5, 2012, Pages 267-273

  Jaben, Elizabeth A ^a   Winters, Jeffrey L ^b  

^a MAYO CLINIC HOSPITAL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

limbic encephalitis; Morvan's syndrome; neuromyotonia; plasma exchange; voltage gated potassium channel antibody

Indexed keywords

ANTIBODY; AZATHIOPRINE; CORTICOSTEROID; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RITUXIMAB; SERUM ALBUMIN; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL ANTIBODY;

ADULT; AGED; BLEEDING; CLINICAL ARTICLE; FEMALE; FLUID THERAPY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL RECORD REVIEW; MEMORY DISORDER; MYOKYMIA; NEUROLOGIC DISEASE; PARANEOPLASTIC NEUROPATHY; PERSONALITY DISORDER; PLASMAPHERESIS; REVIEW; SEIZURE; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; AGED; ANTIBODIES; AUTOANTIBODIES; BLOOD PRESERVATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIMBIC ENCEPHALITIS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PLASMA EXCHANGE; POTASSIUM CHANNELS, VOLTAGE-GATED; RETROSPECTIVE STUDIES; RISK;

EID: 84867229654     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.21233     Document Type: Review

References (29)

1. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ,. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008; 70: 1883-1890.
2. Rueff L, Graber JJ, Bernbaum M, Kuzniecky RI,. Voltage-gated potassium channel antibody-mediated syndromes: A spectrum of clinical manifestations. Rev Neurol Dis 2008; 5: 65-72.
3. Merchut MP,. Management of voltage-gated potassium channel antibody disorders. Neurol Clin 2010; 28: 941-959.
4. Kleopa KA, Elman LB, Lang B, Vincent A, Scherer SS,. Neuromyotonia and limbic encephalitis sera target mature Shaker-type K+ channels: subunit specificity correlates with clinical manifestations. Brain 2006; 129: 1570-1584.
5. Ahmad A, Doran M,. A treatable form of amnesia and rapid cognitive decline. Q J Med 2009; 102: 145-146.
6. Heidenreich F, Vincent A,. Antibodies to ion-channel proteins in thymoma with myasthenia, neuromyotonia, and peripheral neuropathy. Neurology 1998; 50: 1483-1485.
7. Jacob S, Irani SR, Rajabally YA, Grubneac A, Walters RJ, Yazaki M, Clover L, Vincent A,. Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatry 2008; 79: 202-204.
8. Buckley C, Oger J, Clover L, Tuzun E, Carpenter K, Jackson M, Vincent A,. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001; 50: 73-78.
9. Bady B, Chauplannaz G, Vial C,. Autoimmune aetiology for acquired neuromyotonia. Lancet 1991; 338: 1330.
10. Sinha S, Newsom-Davis J, Mills K, Byrne N, Lang P, Vincent A,. Autoimmune aetiology for acquired neuromyotonia (Isaac's syndrome). Lancet 1991; 338: 75-77.
11. Newsom-Davis J, Mills KR,. Immunological associations of acquired neuromyotonia (Isaac's syndrome). Report of five cases and literature review. Brain 1993; 116: 453-469.
12. Wintzen AR, Van Dijk JG, Brand A,. Neuromyotonia with early response to plasmapheresis associated with proximal action myoclonus with late response to plasmapheresis. Muscle Nerve 1994; 17: S221.
13. Shillito P, Molenaar PC, Vincent A, Leys K, Zheng W, van den Berg RJ, Plomp JJ, Van Kempen GTH, Chauplannaz G, Wintzen AR, van Dijk JG, Newsom-Davis J,. Acquired neuromyotonia: Evidence for autoantibodies directed against K+ channels of peripheral nerves. Ann Neurol 1995; 38: 714-722.
14. Martinelli P, Patuelli A, Minardi C, Cau A, Riveria AM, Pozza FD,. Neuromyotonia, peripheral neuropathy and myasthenia gravis. Muscle Nerve 1996; 19: 505-510.
15. van den Berg JSP, van Engelen BGM, Boerman RH, de Baets MH,. Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin. J Neurol 1999; 246: 623-625.
16. Hayat GR, Kulkantrakorn K, Campbell WW, Giuliani MJ,. Neuromyotonia: autoimmune pathogenesis and response to immune modulating therapy. J Neurol Sci 2000; 181: 38-43.
17. Antozzi C, Binelli S, Frassoni C, Ciano C, Vincent A, Andreetta F, Panzica F, Franceschetti S, Confolonieri P, Montegazza R,. Immunotherapy responsive startle with antibodies to voltage gated potassium channels. J Neurol Neurosurg Psychiatry 2007; 78: 1281-1290.
18. Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J,. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701-712.
19. Harrower T, Foltynie T, Kartsounis L, De Silva RN, Hodges JR,. A case of voltage-gated potassium channel antibody-related limbic encephalitis. Neurology 2006; 2: 339-343.
20. Ahmad A, Ramakrishna S, Meara J, Doran M,. Autoimmune limbic encephalitis: a reversible form of rapidly progressive amnesia and seizures. J R Coll Physicians Edinb 2010; 40: 123-125.
21. Madrid A, Gil-Peralta A, Gil-Neciga E, Gonzalez JR, Jarrin S,. Morvan's fibrillary chorea: remission after plasmapheresis. J Neurol 1996; 243: 350-353.
22. Maselli RA, Agius M, Lee EK, Bakshi N, Mandler RN, Ellis W,. Morvan's fibrillary chorea. Electrodiagnostic and in vitro microelectrode findings. Ann NY Acad Sci 1998; 841: 497-500.
23. Agius MA, ZHU Shan, Lee EK, Aarli JA, Kirvan C, Fairclough RH, Maselli R,. Antibodies to AChR, synapse-organizing proteins, titin, and other muscle proteins in Morvan's fibrillary chorea. Ann NY Acad Sci 1998; 841: 522-524.
24. Lee EK, Maselli RA, Ellis WG, Agius MA,. Morvan's fibrillary chorea: a paraneoplastic manifestations of thymoma. J Neurol Neurosurg Psychiatry 1998; 65: 857-862.
25. Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, Baruzzi A, Carey T, Gambetti P, Lugaresi E, Montagna P,. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001; 124: 2417-2426.
26. Cottrell DA, Blackmore KJ, Fawcett PRW, Birchall D, Vincent A, Barnard S, Walls TJ,. Sub-acute presentation of Morvan's syndrome after thymectomy. J Neurol Neurosurg Psychiatry 2004; 75: 1504-1509.
27. Josephs KA, Silber MH, Fealey RD, Nippoldt TB, Auger RG, Vernino S,. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 2004; 21: 440-445.
28. Vernino S, Kryzer TJ, Lennon AV,. Autoimmune autonomic neuropathy and neuromuscular hyperexcitability disorders. In:, Rose NR, Hamilton RG, Detrick B, editors. Manual of Clinical and Laboratory Immunology, 6th ed. Washington DC: ASM Press. 2002. Chapter 114, pp 1013-1017
29. Szczepiorkowski ZM, Winters JL, Bandarenko N, Kim HC, Linenberger ML, Marques MB, Sarode R, Schwartz J, Weinstein R, Shaz B,. Guidelines on the use of therapeutic apheresis in clinical practice-Evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis. J Clin Apher 2010; 25: 83-177.